Tamer Basel Shabaneh (Tamer B Shabaneh)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Journal for immunotherapy of cancer

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for immunotherapy of cancer 12 (2) (2024)
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for immunotherapy of cancer 12 (2) (2024)
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for immunotherapy of cancer 12 (2) (2024)
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for immunotherapy of cancer 12 (2) (2024)
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for immunotherapy of cancer 12 (2) (2024)
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for immunotherapy of cancer 12 (2) (2024)
Tamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, Kristen R Shimp, Brandon W Seaton, Ekram A Gad, Carla A Jaeger-Ruckstuhl, Sylvain Simon, Amanda L Koehne, Jason P Price, James M Olson, Benjamin G Hoffstrom, David Jellyman, Stanley R Riddell
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. Journal for immunotherapy of cancer 12 (2) (2024)
Emilio Sanseviero, Erin M O'Brien, Jenna R Karras, Tamer Basel Shabaneh, Bülent Arman Aksoy, Wei Xu, Cathy Zheng, Xiangfan Yin, Xiaowei Xu, Giorgos C Karakousis, Ravi K Amaravadi, Brian Nam, Mary Jo Turk, Jeff Hammerbacher, Mark P Rubinstein, Lynn M Schuchter, Tara C Mitchell, Jingjing Liu, Erica L Stone
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control. Cancer immunology research 7 (8) (2019)

Tamer Basel Shabaneh.css-eqlu8i{font-size:small;padding-left:4px;} (Tamer B Shabaneh)

Publication Activity (10 Years)

Top Topics

Top Venues

Tamer Basel Shabaneh (Tamer B Shabaneh)